The cumulative evidence to date suggests that IL-22 plays a role in the immune-inflammatory system in context of obesity and its metabolic consequences, but that the role of IL-22 in metabolic regulation is extremely complex and thus still controversial [27,43,44,45]. Here, IL22 is linked to obesity due to melanocortin 4 receptor deficiency.